Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michail Vikelis

Showing results (21-30 of 68) with videos related to

Pageof 7
Sort By:
Toxins|May 27, 2022
Assessing the Significance of the Circadian Time of Administration on the Effectiveness and Tolerability of OnabotulinumtoxinA for Chronic Migraine ProphylaxisEmmanouil V Dermitzakis, Michail Vikelis, George S Vlachos, et al.
The Journal of Headache and Pain|December 16, 2005
Headache attributed to unruptured saccular aneurysm, mimicking hemicrania continuaMichail Vikelis, Michail Xifaras, Georgios Magoufis, et al.
Expert Review of Neurotherapeutics|June 16, 2022
A systematic review with expert opinion on the role of gepants for the preventive and abortive treatment of migraineAndreas A Argyriou, Elisa Mantovani, Dimos-Dimitrios Mitsikostas, et al.
Expert Review of Neurotherapeutics|July 22, 2021
Beyond chronic migraine: a systematic review and expert opinion on the off-label use of botulinum neurotoxin type-A in other primary headache disordersAndreas A Argyriou, Dimos-Dimitrios Mitsikostas, Elisa Mantovani, et al.
SAGE Open Medicine|January 16, 2016
A prospective non-interventional study for evaluation of quality of life in patients with Alzheimer's disease treated with rivastigmine transdermal patchVassileios Vagenas, Georgios S Vlachos, Nikoleta Vlachou, et al.
Headache|July 30, 2011
Headache in systemic lupus erythematosus vs multiple sclerosis: a prospective comparative studyChristina G Katsiari, Michail Vikelis, Eleftheria S Paraskevopoulou, et al.
The Journal of Headache and Pain|September 19, 2016
Onabotulinumtoxin-A treatment in Greek patients with chronic migraineMichail Vikelis, Andreas A Argyriou, Emmanouil V Dermitzakis, et al.
Medicina (Kaunas, Lithuania)|January 21, 2023
Results of a Web-Based Survey on 2105 Greek Migraine Patients-Second Part: Efficacy of Acute and Prophylactic Migraine Treatments and Corresponding Patients' Reported SatisfactionEmmanouil V Dermitzakis, Aikaterini Kouroudi, Andreas A Argyriou, et al.
The Journal of Headache and Pain|September 19, 2018
Sustained onabotulinumtoxinA therapeutic benefits in patients with chronic migraine over 3 years of treatmentMichail Vikelis, Andreas A Argyriou, Emmanouil V Dermitzakis, et al.
BMC Neurology|November 21, 2022
Results of a Web-based survey of 2105 Greek migraine patients in 2020: demographics, clinical characteristics, burden and the effects of the COVID-19 pandemic on the course of migraineEmmanouil V Dermitzakis, Aikaterini Kouroudi, Andreas A Argyriou, et al.
Pageof 7

Showing results (21-30 of 68) with videos related to

Sort By:
Pageof 7
Toxins|May 27, 2022
Assessing the Significance of the Circadian Time of Administration on the Effectiveness and Tolerability of OnabotulinumtoxinA for Chronic Migraine ProphylaxisEmmanouil V Dermitzakis, Michail Vikelis, George S Vlachos, et al.
The Journal of Headache and Pain|December 16, 2005
Headache attributed to unruptured saccular aneurysm, mimicking hemicrania continuaMichail Vikelis, Michail Xifaras, Georgios Magoufis, et al.
Expert Review of Neurotherapeutics|June 16, 2022
A systematic review with expert opinion on the role of gepants for the preventive and abortive treatment of migraineAndreas A Argyriou, Elisa Mantovani, Dimos-Dimitrios Mitsikostas, et al.
Expert Review of Neurotherapeutics|July 22, 2021
Beyond chronic migraine: a systematic review and expert opinion on the off-label use of botulinum neurotoxin type-A in other primary headache disordersAndreas A Argyriou, Dimos-Dimitrios Mitsikostas, Elisa Mantovani, et al.
SAGE Open Medicine|January 16, 2016
A prospective non-interventional study for evaluation of quality of life in patients with Alzheimer's disease treated with rivastigmine transdermal patchVassileios Vagenas, Georgios S Vlachos, Nikoleta Vlachou, et al.
Headache|July 30, 2011
Headache in systemic lupus erythematosus vs multiple sclerosis: a prospective comparative studyChristina G Katsiari, Michail Vikelis, Eleftheria S Paraskevopoulou, et al.
The Journal of Headache and Pain|September 19, 2016
Onabotulinumtoxin-A treatment in Greek patients with chronic migraineMichail Vikelis, Andreas A Argyriou, Emmanouil V Dermitzakis, et al.
Medicina (Kaunas, Lithuania)|January 21, 2023
Results of a Web-Based Survey on 2105 Greek Migraine Patients-Second Part: Efficacy of Acute and Prophylactic Migraine Treatments and Corresponding Patients' Reported SatisfactionEmmanouil V Dermitzakis, Aikaterini Kouroudi, Andreas A Argyriou, et al.
The Journal of Headache and Pain|September 19, 2018
Sustained onabotulinumtoxinA therapeutic benefits in patients with chronic migraine over 3 years of treatmentMichail Vikelis, Andreas A Argyriou, Emmanouil V Dermitzakis, et al.
BMC Neurology|November 21, 2022
Results of a Web-based survey of 2105 Greek migraine patients in 2020: demographics, clinical characteristics, burden and the effects of the COVID-19 pandemic on the course of migraineEmmanouil V Dermitzakis, Aikaterini Kouroudi, Andreas A Argyriou, et al.
Pageof 7